Newark, New Castle, USA, May 17, 2023 (GLOBE NEWSWIRE) -- According to a recent report published by Growth Plus Reports, the anti-parathyroid agents market is projected to register a CAGR of 5.2% from 2023 to 2031. The anti-parathyroid agents market research report contains comprehensive data on the market's economics, trends, leading competitors, important geographies, revenue growth drivers, prospects, and in-depth revenue forecasting from 2023 to 2031.
Key Takeaways:
- North America will emerge as a prominent market.
- Increasing demand for drugs to treat parathyroid disorders will support market revenue growth.
- The vitamin D analogue drug class will dominate the global anti-parathyroid agents market in terms of revenue share.
Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/antiparathyroid-agents-market/8935
Anti-parathyroid Agents Market Scope
| Report Attribute | Details |
| CAGR | 5.2% |
| Base Year for Estimation | 2022 |
| Forecast Period | 2023 to 2031 |
| Historical Year | 2021 |
| Segments Covered | Drug Class, Distribution Channel, and Region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Market Drivers
The increasing prevalence of parathyroid disorders such as hyperparathyroidism and hypoparathyroidism will drive the market's revenue growth. Furthermore, aging populations, changes in dietary habits, lifestyle-related factors, and advances in drug delivery technologies are expected to fuel the market's revenue growth. Apart from this, rising healthcare expenditure, favorable reimbursement policies, and an increase in demand for drugs to treat parathyroid disorders are expected to support the market's revenue growth.
Market Segmentation
Growth Plus Reports has analyzed the global anti-parathyroid agents market from three perspectives: Drug Class, Distribution Channel, and Region.
- Based on the drug class, the anti-parathyroid agents market is segmented into vitamin D analogue and calcium sensing receptor agonist.
- Based on the distribution channel, the anti-parathyroid agents market is segmented into hospitals, retail pharmacies, and online pharmacies.
Drug Class Segmentation
Based on the drug class, the anti-parathyroid agents market is divided into two categories: vitamin D analogue and calcium-sensing receptor agonist. Since vitamin D analogues are frequently used to treat parathyroid diseases, particularly those that include changes in the metabolism of calcium and vitamin D, it dominates the market.
Regional Growth Dynamics
Based on the region, the global anti-parathyroid agents market is segmented into Europe, North America, Latin America, and the Middle East & Africa. North America dominates the anti-parathyroid agents market with the largest revenue share because of an aging population, a high frequency of parathyroid problems, a developed healthcare infrastructure, high healthcare spending, and growing public awareness of parathyroid disorders.
Request for Customization – https://www.growthplusreports.com/inquiry/customization/anti-parathyroid-agents-market/8935
Competitive Landscape
The top companies in the anti-parathyroid agents market are:
- Sanofi Company
- Amgen Inc.
- AbbVie Inc.
- Teva Pharmaceuticals
- Apotex Corporation
- Marksans Pharma Limited
- Jubilant Generics Limited
- Aurobindo Pharma
- OPKO Pharmaceuticals, LLC.
- Dr. Reddy's Laboratories, Inc
Recent Developments:
- The US FDA authorized MBX 2109 as an orphan drug to manage hypoparathyroidism in July 2022. A parathyroid hormone (PTH) prodrug, MBX 2109, has a prolonged half-life. The goal of the experimental treatment is to provide active PTH peptides gradually.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2021
- Base Year – 2022
- Forecast Years – 2023 to 2031
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2022)
- Regulatory Landscape
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL ANTI-PARATHYROID AGENTS MARKET- ANALYSIS & FORECAST, BY DRUG CLASS
- Vitamin D Analogue
- Calcium Sensing Receptor Agonist
- GLOBAL ANTI-PARATHYROID AGENTS MARKET- ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
ANTI-PARATHYROID AGENTS MARKET TOC
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8935
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on 'Strategic Developments' registered by leading players of the market.
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- 'Business Profile' of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at - https://www.growthplusreports.com/report-store
Browse more latest healthcare reports:
Vibrating Mesh Nebulizer Market by Type (Passive Mesh Nebulizer and Piezoelectric Actuation), End User (Hospitals, Clinics, Home Healthcare) – Global Outlook & Forecast 2023-2031
Next-Generation Sequencing (NGS) Data Analysis Market by Product (Services, NGS Commercial Software, Others), Mode (In-house Data Analysis, Outsourced Data Analysis), Read Length (Short Read Sequencing, Long Read Sequencing), End User (Academic Research, Clinical Research) – Global Outlook & Forecast 2023-2031
Hypersensitivity Pneumonitis Market by Type (Sub-acute Hypersensitivity Pneumonitis, Acute Hypersensitivity Pneumonitis), Treatment (Immunosuppressive, Corticosteroids) – Global Outlook & Forecast 2023-2031
Endodontic Files Market by Type (Manual, Rotary), Material (Stainless Steel, Nickel-titanium), End User (Hospitals & OPDs, Dental Clinics, Others) – Global Outlook & Forecast 2023-2031
Langerhans Cell Histiocytosis Treatment Market by Drug Class (Corticosteroids, Nonsteroidal anti-inflammatory drugs), Distribution Channel (Hospital Pharmacies, Online Pharmacies) – Global Outlook & Forecast 2023-2031
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
